Stay updated on Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial

Sign up to get notified when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added two editorial notes: PubMed-derived publications may not all be about the study, and the page now shows revision v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T04:24:47.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Expanded results section now includes granular safety data (TEAEs/SAEs by SOC and PT) for 1-year follow-up and the change from baseline in LV ejection fraction, across dosing cohorts.
    Difference
    15%
    Check dated 2025-11-19T22:12:21.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    External reference links were added to the Study Results page, including PubMed articles (40753271, 40583275, 40583273, 40579547) and government information sites (hhs.gov, nih.gov, nlm.gov, ncbi.nlm.gov, usa.gov).
    Difference
    0.2%
    Check dated 2025-10-29T10:12:23.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-07T23:14:04.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version bump: replacing v3.0.2 with v3.1.0 in the page metadata.
    Difference
    0.0%
    Check dated 2025-09-30T02:30:34.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Two new references about fordadistrogene movaparvovec in Duchenne muscular dystrophy were added, while the same two references were removed but replaced with online-ahead-of-print identifiers—resulting in a minor bibliographic update rather than a substantive page content change.
    Difference
    0.7%
    Check dated 2025-09-22T23:38:35.000Z thumbnail image

Stay in the know with updates to Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of PF-06939926 Gene Therapy in Duchenne Clinical Trial page.